Connection
Cindy O'Bryant to Midazolam
This is a "connection" page, showing publications Cindy O'Bryant has written about Midazolam.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.219 |
|
|
|
-
Miller C, Sommavilla R, O'Bryant CL, Barve M, Dowlati A, Luke JJ, Khatun M, Morris T, Cullberg M. Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2024 Aug; 94(2):223-235.
Score: 0.219